INTERFERON GAMMA (IFN-γ) IN EARLY DIABETIC KIDNEY DISEASE IS ASSOCIATED WITH PROGRESSION TO KIDNEY FAILURE

Back

E-Poster

https://storage.unitedwebnetwork.com/files/1099/ade8bf20d6af1a6d996aa834626f27d7.pdf

Abstract Title

First Name *

Viji

Last Name *

Nair

Co-author 1

Jennifer L. Harder jlharder@med.umich.edu University of Michigan Nephrology Ann Arbor

Co-author 2

Jamal El Saghir ejamal@med.umich.edu University of Michigan Nephrology Ann Arbor

Co-author 3

Felix H. Eichinger eichinge@umich.edu University of Michigan Nephrology Ann Arbor

Co-author 4

Helen Looker helen.looker@nih.gov National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health Chronic Kidney Disease Section Phoenix

Co-author 5

Shannon M. Harlan harlan_shannon_marie@lilly.com Eli Lilly and Company Eli Lilly and Company Indianapolis

Co-author 6

Hana Baker baker_hana_e@lilly.com Eli Lilly and Company Eli Lilly and Company Indianapolis

Co-author 7

Frank C. Brosius fbrosius@arizona.edu University of Arizona Medical Center Nephrology Tucson

Co-author 8

Kevin L. Duffin duffin_kevin_l@lilly.com Eli Lilly and Company Eli Lilly and Company Indianapolis

Co-author 9

Robert G. Nelson nelson@phx.niddk.nih.gov National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health Chronic Kidney Disease Section Phoenix

Co-author 10

Matthias Kretzler kretzler@med.umich.edu University of Michigan Nephrology Ann Arbor

Co-author 11

Wenjun Ju wenjunj@med.umich.edu University of Michigan Nephrology Ann Arbor

Co-author 12

Co-author 13

Co-author 14

Co-author 15